These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 19187444)
1. Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum. Maccarrone M; De Chiara V; Gasperi V; Viscomi MT; Rossi S; Oddi S; Molinari M; Musella A; Finazzi-Agrò A; Centonze D J Neurochem; 2009 Apr; 109(2):371-81. PubMed ID: 19187444 [TBL] [Abstract][Full Text] [Related]
2. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Musella A; De Chiara V; Rossi S; Cavasinni F; Castelli M; Cantarella C; Mataluni G; Bernardi G; Centonze D Neuroscience; 2010 May; 167(3):864-71. PubMed ID: 20219639 [TBL] [Abstract][Full Text] [Related]
3. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. Bari M; Spagnuolo P; Fezza F; Oddi S; Pasquariello N; Finazzi-Agrò A; Maccarrone M J Immunol; 2006 Oct; 177(8):4971-80. PubMed ID: 17015679 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum. De Chiara V; Motta C; Rossi S; Studer V; Barbieri F; Lauro D; Bernardi G; Centonze D Neuroscience; 2013 Oct; 250():232-9. PubMed ID: 23856068 [TBL] [Abstract][Full Text] [Related]
5. Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Maccarrone M; Rossi S; Bari M; De Chiara V; Rapino C; Musella A; Bernardi G; Bagni C; Centonze D Neuropsychopharmacology; 2010 Jun; 35(7):1500-9. PubMed ID: 20393458 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the endocannabinoid system by lipid rafts. Dainese E; Oddi S; Bari M; Maccarrone M Curr Med Chem; 2007; 14(25):2702-15. PubMed ID: 17979719 [TBL] [Abstract][Full Text] [Related]
7. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019 [TBL] [Abstract][Full Text] [Related]
8. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Mátyás F; Urbán GM; Watanabe M; Mackie K; Zimmer A; Freund TF; Katona I Neuropharmacology; 2008 Jan; 54(1):95-107. PubMed ID: 17655884 [TBL] [Abstract][Full Text] [Related]
9. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629 [TBL] [Abstract][Full Text] [Related]
10. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045 [TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model. Sepers MD; Smith-Dijak A; LeDue J; Kolodziejczyk K; Mackie K; Raymond LA J Neurosci; 2018 Jan; 38(3):544-554. PubMed ID: 29192125 [TBL] [Abstract][Full Text] [Related]
12. Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. Rimmerman N; Hughes HV; Bradshaw HB; Pazos MX; Mackie K; Prieto AL; Walker JM Br J Pharmacol; 2008 Jan; 153(2):380-9. PubMed ID: 17965731 [TBL] [Abstract][Full Text] [Related]
13. Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. Sarnataro D; Grimaldi C; Pisanti S; Gazzerro P; Laezza C; Zurzolo C; Bifulco M FEBS Lett; 2005 Nov; 579(28):6343-9. PubMed ID: 16263116 [TBL] [Abstract][Full Text] [Related]
14. Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. Ade KK; Lovinger DM J Neurosci; 2007 Feb; 27(9):2403-9. PubMed ID: 17329438 [TBL] [Abstract][Full Text] [Related]
15. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. Thiemann G; van der Stelt M; Petrosino S; Molleman A; Di Marzo V; Hasenöhrl RU Behav Brain Res; 2008 Mar; 187(2):289-96. PubMed ID: 17988751 [TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390 [TBL] [Abstract][Full Text] [Related]